Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Jacobs Pills, Inc.
WARNING LETTER
•Jacobs Pills, Inc.•February 28, 2017

Jacobs Pills, Inc. – FDA Warning Letter, Feb 28, 2017

Record Details

On May 31, 2018, the FDA issued a Warning Letter to Jacobs Pills, Inc. dba The Healthy Choice Apothecary following an inspection from February 22-28, 2017. The inspection revealed that the firm produced drug products that failed to meet the conditions for exemption under Section 503A of the FDCA, and exhibited serious deficiencies in non-sterile drug product manufacturing practices.

Violations included: 1. **Failure to meet 503A conditions**: The firm did not receive valid prescriptions for individually-identified patients for a portion of compounded drugs. Additionally, drug products were compounded using melatonin, which is not subject to a USP/NF monograph, is not a component of an FDA-approved drug, and is not on the 503A bulks list. This renders these products ineligible for exemptions from CGMP, adequate labeling, and FDA approval requirements. 2. **Adulterated Drug Products (CGMP violations)**: Ineligible drug products were manufactured under significant CGMP violations, including failure to reject components not meeting specifications (21 CFR 211.84(e)), failure to ensure expiration dates were supported by stability testing (21 CFR 211.137(a)), and failure to establish and follow adequate written procedures for in-process controls and batch uniformity (21 CFR 211.110(a

Company
Jacobs Pills, Inc.
Inspection date
February 28, 2017
Product type
Drugs
Office
New Jersey District Office
Person
  • Diana Amador-Toro (District Director)
View Company Profile

ID · 17402195-f32a-4638-8f46-a23d30a32cd7

Violation Codes10
21 U.S.C. 353a21 U.S.C. 352(f)(1)21.U.S.C. 355(a)21 U.S.C. 331(k)21 CFR 211.84(e)21 CFR 211.137(a)21 CFR 211.110(a)21 CFR 21021 CFR 21121 U.S.C. 351(a)(2)(B)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Jacobs Pills, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.